Colchicine to prevent heart rhythm problems after heart bypass surgery
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether taking colchicine (a common anti-inflammatory medication) before and after bypass heart surgery can prevent atrial fibrillation—an irregular heartbeat that sometimes occurs after surgery. Researchers hope this simple treatment might reduce complications and improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 20 years old and scheduled for elective coronary artery bypass grafting (heart bypass surgery)
- You can take oral medication (pills by mouth) before and after your surgery
- You have no history of atrial fibrillation or atrial flutter (irregular heartbeats) before surgery
- Your kidneys and liver are functioning well enough for the study drug
- You are not pregnant, breastfeeding, or taking certain medications that interact with colchicine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug colchicine can reduce the chance of developing atrial fibrillation (an irregular heart rhythm) after open-heart surgery. If it works, it could help you recover more smoothly.
This trial tests whether the drug colchicine can reduce inflammation after planned coronary artery bypass graft (CABG) surgery. It may help patients recover better by lowering inflammatory markers.
This study tests whether a low dose of colchicine, an anti-inflammatory drug, can help prevent the graft (new blood vessel) from failing after heart bypass surgery. It's for people who just had a bypass and are still in the hospital.
This trial tests whether a low dose of colchicine, an anti-inflammatory medication, can help prevent bypass grafts from closing after heart surgery. You would take this medication for a set period after your coronary artery bypass graft (CABG) surgery.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This study tests whether the drug colchicine can reduce inflammation and protect organs during and after planned heart surgery. It may help people recover better.
Hear when a new Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting (CABG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.